United States Biotechnology & Medical Research

Spruce Biosciences Inc (SPRB)

Track

The most recent insider trading activity for Spruce Biosciences Inc. occurred on October 6, 2025, involving Parkman Healthcare Partners LLC. This entity executed multiple buy and sell transactions on that date. As these transactions occurred more than three months ago, no further context regarding recent stock performance is provided.
Ticker: SPRB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Spruce Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 6 Oct 2025
Value US$2,460,500.86 | Price 452.50 | Shares 96,881 (-47.3%)
Sale 6 Oct 2025
Value US$2,196,654.30 | Price 108.43 | Shares 47,862 (+3.7%)
Buy 6 Oct 2025
Value US$4,585.16 | Price 17.91 | Shares 256 (+24.4%)
Sale 6 Oct 2025
Value US$436.39 | Price 17.46 | Shares 25 (-2.3%)
Sale 6 Oct 2025
Value US$4,483.72 | Price 19.33 | Shares 232 (-17.8%)
Buy 6 Oct 2025
Value US$4,585.16 | Price 17.91 | Shares 256 (+24.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-15 2025-10-06 S Sale
Parkman Healthcare Partners LLC
Large shareholder
96,881 -47.3%
452.50
US$2,460,501 		96,881 -47.3% 452.50 US$2,460,501
2025-10-15 2025-10-06 S Sale
Parkman Healthcare Partners LLC
Large shareholder
47,862 +3.7%
108.43
US$2,196,654 		47,862 +3.7% 108.43 US$2,196,654
2025-10-15 2025-10-06 B Purchase
Parkman Healthcare Partners LLC
Large shareholder
77,762 -38.8%
293.76
US$4,118,734 		77,762 -38.8% 293.76 US$4,118,734
2025-10-08 2025-10-06 S Sale
Parkman Healthcare Partners LLC
Large shareholder
25 -2.3%
17.46
US$436 		25 -2.3% 17.46 US$436
2025-10-08 2025-10-06 S Sale
Parkman Healthcare Partners LLC
Large shareholder
232 -17.8%
19.33
US$4,484 		232 -17.8% 19.33 US$4,484
2025-10-08 2025-10-06 B Purchase
Parkman Healthcare Partners LLC
Large shareholder
256 +24.4%
17.91
US$4,585 		256 +24.4% 17.91 US$4,585
2024-03-25 2024-03-21 S Sale
2.3
Novo Holdings A/S
Large shareholder
465,021 -15.4%
0.75
US$350,951 		465,021 -15.4% 0.75 US$350,951
2024-03-20 2024-03-20 S Sale
2.3
Novo Holdings A/S
Large shareholder
359,979 -10.7%
0.73
US$264,081 		359,979 -10.7% 0.73 US$264,081
2024-03-20 2024-03-19 S Sale
2.3
Novo Holdings A/S
Large shareholder
593,000 -14.9%
0.76
US$447,715 		593,000 -14.9% 0.76 US$447,715
2024-03-20 2024-03-18 S Sale
2.3
Novo Holdings A/S
Large shareholder
842,020 -17.5%
0.77
US$647,008 		842,020 -17.5% 0.77 US$647,008
2024-03-18 2024-03-18 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
4,810,020
0.81
US$3,899,002 		4,810,020 0.81 US$3,899,002
2024-03-18 2024-03-14 S Sale
2.3
Novo Holdings A/S
Large shareholder
1,912,316 -28.4%
0.89
US$1,698,902 		1,912,316 -28.4% 0.89 US$1,698,902
2024-03-14 2024-03-14 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
1,912,316
4.96
US$9,485,087 		1,912,316 4.96 US$9,485,087
2023-05-16 2023-02-16 B Purchase
2.3
O'Donnell Niall
Non-Executive Director
630,400 +90.6%
3.17
US$1,998,368 		630,400 +90.6% 3.17 US$1,998,368
2023-02-21 2023-02-16 B Purchase
2.3
Novo Holdings A/S
Large shareholder
2,208,000 +48.9%
3.17
US$6,999,360 		2,208,000 +48.9% 3.17 US$6,999,360
2021-05-21 2021-05-20 PlS Planned sale
SIMPSON CAMILLA V
Non-Executive Director
334 -100.0%
15.29
US$5,107 		334 -100.0% 15.29 US$5,107
2021-05-21 2021-05-19 S Sale
2.3
Novo Holdings A/S
Large shareholder
475,000 -9.5%
13.90
US$6,602,500 		475,000 -9.5% 13.90 US$6,602,500
2021-05-04 2021-04-30 PlS Planned sale
SIMPSON CAMILLA V
Non-Executive Director
14,045 -100.0%
16.14
US$226,664 		14,045 -100.0% 16.14 US$226,664
2020-10-16 2020-10-14 B Purchase
1.5
Muralidhar Bali
Non-Executive Director
200,000 +12.6%
15.00
US$3,000,000 		200,000 +12.6% 15.00 US$3,000,000
2020-10-16 2020-10-14 B Purchase
HANSSON JONAS
Non-Executive Director
250,000 +14.0%
15.00
US$3,750,000 		250,000 +14.0% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
HealthCap VIII, L.P.

Former 10% Owner
250,000 +14.0%
15.00
US$3,750,000 		250,000 +14.0% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
2.3
Novo Holdings A/S
Large shareholder
250,000 +5.3%
15.00
US$3,750,000 		250,000 +5.3% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
1.3
RiverVest Venture Fund III, L.P.
Large shareholder
250,000 +13.2%
15.00
US$3,750,000 		250,000 +13.2% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
3.3
Omega Fund VI, L.P.

Former 10% Owner
250,000 +13.1%
15.00
US$3,750,000 		250,000 +13.1% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
2.3
O'Donnell Niall
Non-Executive Director
250,000 +56.1%
15.00
US$3,750,000 		250,000 +56.1% 15.00 US$3,750,000
2020-10-16 2020-10-14 B Purchase
Chaya Moghrabi Dina
Non-Executive Director
250,000 +13.1%
15.00
US$3,750,000 		250,000 +13.1% 15.00 US$3,750,000
Explore more

More insider trading research around Spruce Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America